These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6331435)

  • 1. Prolactin receptors on human lymphocytes and their modulation by cyclosporine.
    Russell DH; Matrisian L; Kibler R; Larson DF; Poulos B; Magun BE
    Biochem Biophys Res Commun; 1984 Jun; 121(3):899-906. PubMed ID: 6331435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.
    Russell DH; Kibler R; Matrisian L; Larson DF; Poulos B; Magun BE
    J Immunol; 1985 May; 134(5):3027-31. PubMed ID: 2984281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin. Mechanism of action: antagonism of the prolactin receptor.
    Larson DF
    Prog Allergy; 1986; 38():222-38. PubMed ID: 3014545
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of cyclosporine on ornithine decarboxylase induction with mitogens, antigens, and lymphokines.
    Fidelus RK; Laughter AH; Twomey JJ; Taffet SM; Haddox MK
    Transplantation; 1984 Apr; 37(4):383-7. PubMed ID: 6231749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-induced polyamine biosynthesis in spleen and thymus: specific inhibition by cyclosporine.
    Russell DH; Larson DF
    Immunopharmacology; 1985 Jun; 9(3):165-74. PubMed ID: 2991164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptides.
    Russell DH; Buckley AR; Montgomery DW; Larson NA; Gout PW; Beer CT; Putnam CW; Zukoski CF; Kibler R
    J Immunol; 1987 Jan; 138(1):276-84. PubMed ID: 3097147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.
    Hiestand PC; Mekler P; Nordmann R; Grieder A; Permmongkol C
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2599-603. PubMed ID: 2939454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action: ciclosporin- and prolactin-mediated control of immunity.
    Hiestand PC; Mekler P
    Prog Allergy; 1986; 38():239-46. PubMed ID: 3014546
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin A and rabbit mammary prolactin receptors.
    Mahajan PB; Ebner KE
    Biochem Biophys Res Commun; 1985 Dec; 133(2):753-8. PubMed ID: 3002357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A.
    Matera L; Muccioli G; Cesano A; Bellussi G; Genazzani E
    Brain Behav Immun; 1988 Mar; 2(1):1-10. PubMed ID: 3179506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocytic hormonal receptors (author's transl)].
    Arrang JM; Bidart JM
    Ann Biol Clin (Paris); 1980; 38(5):283-92. PubMed ID: 6258460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes.
    Stuart CA; Meehan RT; Neale LS; Cintron NM; Furlanetto RW
    J Clin Endocrinol Metab; 1991 May; 72(5):1117-22. PubMed ID: 1850753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cyclosporine on canine lymphocyte activity.
    Payne JA; Herrod HG; Buice R
    J Clin Lab Immunol; 1986 Aug; 20(4):177-81. PubMed ID: 3531520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells.
    Rosoff PM; Terres G
    J Cell Biol; 1986 Aug; 103(2):457-63. PubMed ID: 3015982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes.
    Bijsterbosch MK; Klaus GG
    Immunology; 1985 Nov; 56(3):435-40. PubMed ID: 3000926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative fluorescence analysis of cyclosporine binding to human leukocytes.
    Ryffel B; Willard-Gallo KE; Tammi K; Loken MR
    Transplantation; 1984 Mar; 37(3):276-80. PubMed ID: 6367167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.
    Schwartz RH; Bianco AR; Handwerger BS; Kahn CR
    Proc Natl Acad Sci U S A; 1975 Feb; 72(2):474-8. PubMed ID: 164655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels.
    Rapaport R; Sills IN; Green L; Barrett P; Labus J; Skuza KA; Chartoff A; Goode L; Stene M; Petersen BH
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2612-9. PubMed ID: 7673403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine A allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytes.
    Ryffel B; Müller S; Foxwell B
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1199-201. PubMed ID: 3079016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.